Prescription pad with naloxone written on it.
·
5 MIN READ

New guidance: Who can benefit from naloxone co-prescribing

The opioid-overdose antidote naloxone saves lives. Co-prescribing it to patients at risk for overdose provides a tangible and timely option for care.

Overdose Epidemic
·
2 MIN READ

Sept. 7, 2017: State Advocacy Update

New opioid-related education and treatment resources in the latest AMA efforts to advocate for state and local health care.

Advocacy Update
·
7 MIN READ

Aug. 24, 2017: National Advocacy Update

Hardship exception, EHR incentive programs and more in the latest AMA national health care advocacy news.

Advocacy Update
·
3 MIN READ

Aug. 24, 2017: Judicial Advocacy Update

Learn how the AMA advises in a PDMP case that unwarranted disclosure of PDMP data to law enforcement could compromise care.

Advocacy Update
·
4 MIN READ

Aug. 10, 2017: State Advocacy Update

New opioid-related reports focus on mortality data, women, cancer and hospitalizations and more in AMA's latest efforts to advocate for state and local health care.

Advocacy Update
·
4 MIN READ

At Brown, syllabus covers treating opioid-use disorder

A program at the Warren Alpert Medical School of Brown University is creating physicians equipped to treat opioid-use disorder as residents.

Overdose Epidemic
·
5 MIN READ

June 29, 2017: State Advocacy Update

Nevada governor vetoes balance-billing legislation and AMA's opioid microsite in the latest state and local advocacy efforts.

Advocacy Update
·
2 MIN READ

Report shows inconsistent coverage in substance use disorder treatment

A new report from the Addiction Solutions Campaign reveals significant challenges that patients face when seeking treatment for a substance use disorder

Press Releases
·
3 MIN READ

Physicians call for better prescription drug-monitoring programs

Use of state prescription drug monitoring programs has grown significantly, but gaps remain—including a lack of data from VA pharmacies.

Overdose Epidemic